Phytochemicals and Hallmarks of Cancer
From Molecules to Medicine
- 1st Edition - June 23, 2026
- Latest edition
- Editors: Gautam Sethi, Lekshmi R. Nath
- Language: English
Phytochemicals and Hallmarks of Cancer: From Molecules to Medicine delves into the potential of phytomedicine to effectively address both established and emerging hallmarks of can… Read more
Description
Description
By addressing these knowledge and information needs Phytochemicals and Hallmarks of Cancer: From Molecules to Medicine is designed to be accessible to clinicians and researchers alike in the field of phytochemical applications in medicine.
Key features
Key features
- Provides a detailed overview of the molecular mechanisms through which phytochemicals can modulate various hallmarks of cancer
- Discusses the potential of phytochemicals to reverse the metastatic process via inhibition of migration, invasion, and angiogenesis
- Covers the implication of natural products as apoptosis inducers
Readership
Readership
Table of contents
Table of contents
2. Targeting autophagy with phytochemicals
3. Impact of phytochemicals on cancer cell migration, invasion and angiogenesis
4. Phytochemicals as cell cycle modulators
5. Phytochemicals to suppress tumor-promoting inflammation
6. Impact of phytochemicals on cancer-associated Extracellular matrix(ECM)
7. Implication of phytochemicals for cancer immunotherapy
8. Phytochemical mediated re-programming of energy metabolism in cancer
9. Phytoradiotherapy: An Integrative Approach to Cancer Treatment
10. Cancer epigenetic modulation mediated by phytochemicals
11. Natural products as anti-cancer drugs: where do we stand now?
12. Hurdles in clinical translation plant-derived natural products for cancer therapy
Product details
Product details
- Edition: 1
- Latest edition
- Published: June 23, 2026
- Language: English
About the editors
About the editors
GS
Gautam Sethi
Dr. Gautam Sethi is a tenured Associate Professor in the Department of Pharmacology at the Yong Loo Lin School of Medicine, National University of Singapore. His research focuses on elucidating the molecular mechanisms underlying cancer initiation and progression, particularly the activation of oncogenic transcription factors by carcinogens and inflammatory agents, and the identification of novel therapeutic inhibitors. Dr. Sethi has made substantial and direct scholarly contributions to the fields of gut microbiota, cancer pathophysiology, and host–microbiome interactions, with particular emphasis on immunotherapy, tumor microenvironment modulation, metabolic signaling, and therapy response prediction. He has authored numerous peer reviewed research and review articles in high impact journals, received multiple international awards, and serves on the editorial boards of several international journals.
LN